News

Upcoming Class Action Against Match Group, Inc. (MTCH)

Upcoming Class Action Against Match Group, Inc. (MTCH)

Upcoming Class Action Against Match Group, Inc. (MTCH)

The Gross Law Firm recently announced a class action notice aimed at shareholders of Match Group, Inc. (NASDAQ: MTCH). This notice serves as an important call to action for shareholders who purchased shares during a specified class period. The firm encourages these individuals to reach out regarding their potential appointment as lead plaintiffs.

Details of the Class Action

Shareholders who acquired shares of MTCH within the indicated class period are urged to contact The Gross Law Firm. They can potentially qualify as lead plaintiffs, although it is not a requirement for participating in any recovery from the case. The firm is committed to advocating for shareholders who have suffered financial losses due to allegedly misleading statements made by Match Group.

Understanding the Allegations

The allegations brought forth in the complaint suggest that Match Group significantly understated the challenges facing Tinder, one of its primary business units. It is claimed that this understatement led to a misrepresentation of the risks regarding Tinder's monthly active user count recovery, thus affecting Match Group's overall business operations and financial projections.

Significance of the Class Period

The specified class period spans from May 2, 2023, through November 6, 2024. Investors who acquired stocks during this time frame may be eligible for participation in the recovery process. Reflecting on this period, stakeholders need to act promptly to safeguard their rights.

Important Deadlines

The deadline for shareholders to register for this class action is January 24, 2025. Investors are strongly advised not to delay in submitting their information to ensure they do not miss out on this opportunity for recovery.

Steps for Shareholders

Upon registration as a shareholder who purchased MTCH shares within the designated timeframe, participants will be enrolled in a portfolio monitoring service. This service is designed to provide regular updates throughout the lifecycle of the case. The firm affirms that there are no costs associated with participation, allowing investors to engage without financial burden.

Why Choose The Gross Law Firm?

The Gross Law Firm holds a national reputation for advocating on behalf of investors affected by false representations and fraudulent practices. Their mission is dedicated to protecting investor rights and ensuring compliance with ethical business practices. They aim to recover losses incurred by investors when companies mislead stakeholders through fraudulent claims.

Contact Information

For more information, individuals are encouraged to contact The Gross Law Firm directly. Below are the contact details to reach out:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY 10018
Phone: (646) 453-8903

Frequently Asked Questions

What is the class action about?

The class action is regarding alleged misleading statements made by Match Group, Inc. about the performance of Tinder, impacting shareholder value.

Who can participate in this class action?

Shareholders who purchased shares of MTCH between May 2, 2023, and November 6, 2024 are eligible to participate.

What is the deadline to register?

The deadline for registration is January 24, 2025. It is crucial for shareholders to register before this date.

Are there any costs associated with participating?

No, there are no costs or obligations for shareholders to participate in this case.

How will I be kept informed about the case?

Registered shareholders will receive updates through a portfolio monitoring service throughout the lifecycle of the case.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Cars.com Inducement Awards: New CPO Earns Stock Boost

Updated Category News Views 28

Revving Up With Incentives: A Strategic Move by Cars.com Ever seen a stock maneuver that feels more like a chess play than a plain deal? On November 5, 2026, Cars.com (NYSE: CARS) fired up quite a strategic engine. They handed out a heap of restricted stock units—373,345 to be precise—to Mausam Bhatt, freshly minted as their Chief Product Officer. This isn't just your...

Continue Reading
Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 124

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 354

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 170

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 354

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 664

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 117

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 302

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 439

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 586

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading

Top 5 Most Recently Viewed Articles

Verint's Investor Day: Unveiling Key Innovations in CX Automation

Updated Category News Views 254

Exciting Updates from Verint's Investor Day Event Verint® (Nasdaq: VRNT), known as The CX Automation Company™, has recently held its much-anticipated Investor Day, highlighting significant advancements and outlined strategies aimed at shaping the future of customer experience (CX). The event kicked off with CEO Dan Bodner expressing enthusiasm about discussing the...

Continue Reading
Tri Pointe Homes, Inc. Delivers Strong Q3 2025 Performance

Updated Category News Views 255

Tri Pointe Homes Reports Outstanding Third Quarter Performance Tri Pointe Homes, Inc. (NYSE: TPH), a leading homebuilder in America, has unveiled strong results for the third quarter of 2025, highlighting significant achievements in home deliveries and financial performance. Key Highlights of Q3 2025 The company has reported a total of 1,217 new home deliveries during...

Continue Reading
Main Street Capital Q3 2024 Results Showcase Strong Growth

Updated Category News Views 144

Main Street Capital Reports Impressive Financial Results Main Street Capital Corporation (NYSE: MAIN) is excited to share its financial results for the third quarter of 2024. With solid performance reflected in higher net investment income and a robust capital position, the company demonstrates its commitment to delivering value to shareholders. Highlights from Q3 2024...

Continue Reading
Rathbones Group Plc's Significant Position in Warpaint London

Updated Category News Views 194

Key Disclosure of Rathbones Group Plc In the financial landscape, transparency is of utmost importance, especially when significant interests in securities come to light. Rathbones Group Plc has provided a crucial disclosure as they maintain an interest in relevant securities of Warpaint London Plc, representing over 1% of their shares. This type of disclosure aligns with...

Continue Reading
Anticipated Surge in Electric Trucks Market to $20.32 Billion

Updated Category News Views 149

Overview of the Electric Trucks Market Growth The global electric trucks market is projected to witness significant growth, with estimates indicating an increase of USD 20.32 billion from recent years through to 2028. This growth trajectory shows an impressive compound annual growth rate (CAGR) of approximately 35.44%. The rising demand for fuel-efficient and low-emission...

Continue Reading